These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25168831)

  • 1. Familial FSGS.
    Pollak MR
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):422-5. PubMed ID: 25168831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
    Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
    Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
    Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
    J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial focal segmental glomerulosclerosis (FSGS) in a Nigerian family and exclusion of mutations in NPHS2,WT1 and APOL1.
    Anochie IC; Eke FU; Okpere AN
    West Afr J Med; 2012; 31(4):273-6. PubMed ID: 23468032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
    Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
    Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.
    Freedman BI; Skorecki K
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):2006-13. PubMed ID: 24903390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
    Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
    J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOL1 kidney risk alleles: population genetics and disease associations.
    Limou S; Nelson GW; Kopp JB; Winkler CA
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):426-33. PubMed ID: 25168832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.
    Genovese G; Tonna SJ; Knob AU; Appel GB; Katz A; Bernhardy AJ; Needham AW; Lazarus R; Pollak MR
    Kidney Int; 2010 Oct; 78(7):698-704. PubMed ID: 20668430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
    Anyaegbu EI; Shaw AS; Hruska KA; Jain S
    Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOL1 localization in normal kidney and nondiabetic kidney disease.
    Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
    J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.
    Larsen CP; Freedman BI
    J Am Soc Nephrol; 2015 Jun; 26(6):1232-5. PubMed ID: 25573910
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathobiology of focal segmental glomerulosclerosis: new developments.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):243-50. PubMed ID: 22357339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The podocin V260E mutation predicts steroid resistant nephrotic syndrome in black South African children with focal segmental glomerulosclerosis.
    Govender MA; Fabian J; Gottlich E; Levy C; Moonsamy G; Maher H; Winkler CA; Ramsay M
    Commun Biol; 2019; 2():416. PubMed ID: 31754646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
    Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
    Kopp JB; Winkler CA; Zhao X; Radeva MK; Gassman JJ; D'Agati VD; Nast CC; Wei C; Reiser J; Guay-Woodford LM; Pollak MR; Hildebrandt F; Moxey-Mims M; Gipson DS; Trachtman H; Friedman AL; Kaskel FJ;
    J Am Soc Nephrol; 2015 Jun; 26(6):1443-8. PubMed ID: 25573908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOL1 and kidney disease.
    Pollak MR; Genovese G; Friedman DJ
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):179-82. PubMed ID: 22257798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does copy number variation of APOL1 gene affect the susceptibility to focal segmental glomerulosclerosis?
    Peng T; Li G; Zhong X; Wang L
    Ren Fail; 2017 Nov; 39(1):500-504. PubMed ID: 28494221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
    Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
    Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.